Statera BioPharma Overview

Statera BioPharma Gross Profit

Gross Profit analysis for STAB.

Quarterly Gross Profit

$501119.00

↑ 315.55% YoY

As of Sep 30, 2022

Annual Gross Profit (TTM)

$2.59M

↑ 2048.82% YoY

Trailing 12 months ending Sep 30, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin